GEFTINIB GEFTINAT TABLETS

Get a Price/Quote

GEFTINIB GEFTINAT TABLETS Specification

Dosage Form
Oral tablet

Salt Composition
Gefitinib 250 mg

Indication
For treatment of locally advanced or metastatic NSCLC with activating EGFR mutations

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 Tablets

Drug Type
Allopathic

Ingredients
Gefitinib

Physical Form
Tablets

Function
Anticancer/EGFR Inhibitor

Recommended For
Non-Small Cell Lung Cancer (NSCLC) patients

Dosage
As prescribed by physician (commonly 250 mg once daily)

Dosage Guidelines
Follow doctors instructions, do not chew or crush tablets

Suitable For
Adults

Quantity
30 tablets per box

Storage Instructions
Store below 30C, protect from light and moisture

Marketed In
Worldwide, widely available in India

Molecular Formula
C22H24ClFN4O3

Brand Name
Geftinat

Shape
Round

Administration Route
Oral

Color
White

Prescription Required
Yes

Shelf Life
24 months from date of manufacture

Product Category
Cancer Chemotherapy

About GEFTINIB GEFTINAT TABLETS

Geftinat- Gefitinib

Brand name: Geftinat
Contains: Gefitinib
Strength: Geftinat 250 Mg
Packing : pack of 30 Tablets
Manufactured By : Natco

Note:Geftinat Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

Targeted Therapy for NSCLC

Geftinat is specifically designed for patients diagnosed with non-small cell lung cancer (NSCLC) featuring EGFR mutations. By inhibiting the EGFR pathway, the tablet directly hinders the growth and spread of cancer cells, enhancing treatment outcomes for eligible patients.

Administration and Dosage Guidelines

Geftinat tablets are taken orally, typically as a single 250 mg dose each day, following your doctors precise instructions. The tablets must be swallowed whole, not chewed or crushed, to preserve their effectiveness. Always adhere strictly to your prescribed regimen for optimal results.

Safety and Storage Information

To ensure Geftinats efficacy, tablets should be stored below 30C, away from light and moisture. The products shelf life is up to 24 months from the manufacturing date. Proper handling and storage are crucial in maintaining the medications quality and potency throughout its usage period.

FAQs of GEFTINIB GEFTINAT TABLETS:

Q: How should Geftinat tablets be taken for best results?

A: Geftinat tablets are to be administered orally, usually once daily at a dose of 250 mg or as prescribed by your doctor. Swallow the tablet whole without chewing or crushing, and take it at the same time each day for consistent therapeutic effects.

Q: What conditions is Geftinat prescribed for?

A: Geftinat is indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults who have activating EGFR mutations, as identified by a healthcare professional.

Q: When should Geftinat not be used without medical advice?

A: Geftinat must not be taken without a prescription. It is essential to use it only under a physicians supervision, as its administration and dosage depend on individual health status and the presence of specific EGFR mutations.

Q: Where can Geftinat be sourced and what packaging is available?

A: Geftinat is widely available in India and distributed worldwide through authorized suppliers, exporters, and traders. Each box contains 30 tablets, providing sufficient medication for a typical monthly course under standard dosing.

Q: What process does Geftinat employ to combat cancer?

A: Geftinat functions as an EGFR inhibitor, blocking signals that promote cancer cell proliferation and survival. It specifically targets and interferes with faulty pathways in cancer cells, thereby helping to slow or stop disease progression.

Q: How should Geftinat be stored to maintain its effectiveness?

A: Store Geftinat tablets below 30C and protect them from light and moisture. Ensure the tablets remain in their original packaging or a safe, dry place, and keep them out of reach of children.

Q: What are the potential benefits of using Geftinat in NSCLC patients?

A: For eligible patients, Geftinat may slow disease progression and improve quality of life by targeting the molecular defects driving NSCLC. This focused treatment often delivers better results compared to traditional chemotherapy in selected cases.

Tell us about your requirement